Becker's Healthcare March 11, 2024
Andrew Cass

R1 RCM has formed a special committee of independent directors to evaluate “strategic alternatives” in the wake of two major shareholders mulling an offer to take the company private.

Private equity firm New Mountain Capital and TCP-ASC — an investment vehicle jointly owned by TowerBrook Capital Partners and Ascension Health Alliance — are considering a potential cash offer of $13.75 per share for all R1’s outstanding stock. New Mountain owns 32.4% of R1 and TowerBrook owns 29.6%.

In a March 11 news release, R1 said it “welcomes open, constructive communications with all stockholders and encourages input that advances our shared goal of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Mergers & Acquisitions / JV, RCM (Revenue Cycle Mgmt), Technology, Trends
Related Articles:
Aspirion lands 7th acquisition in 6 years
Revenue Cycle Risk Takers
Revenue Cycle AI Is Costly and Cumbersome. Here's Why Leaders Are Still Buying In.
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
4 Cornerstones for Successful AI Implementation in Hospital Revenue Cycle Management in 2025

Share This Article